ArticleContemporary clinical trials2015

Phase I clinical evaluation of seasonal influenza hemagglutinin (HA) DNA vaccine prime followed by trivalent influenza inactivated vaccine (IIV3) boost.

Julie E Ledgerwood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.